NFKB1 and inflammatory bowel disease: More recently, Skupsky et al. [17] reported that oral biotin supplementation shows benefit in the induction and maintenance of remission in a dextran sodium sulphate rodent model of IBD by suppressing activation of NF-kB, thus hindering the expression of inflammatory cytokines and helping to maintain integrity of the endothelial barrier of the gut wall.